Search
Filter Results
Displaying 61–70 of 1147 results
-
Aug 20, 2025
jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
Research NewsThe trial is evaluating a cell dose that is 50 percent higher than the highest dose used in a previous Phase 2b trial.
-
Aug 20, 2025
Invisible DisabilityYou cannot tell by looking at me that I am visually impaired. The #1 reaction to my lack of sight confession, though, hands down, is a nervous laugh followed by the person not believing me.
-
Aug 19, 2025
Invisible DisabilityWhen I walk around the neighborhood with my white cane, I still worry about stigma and how people perceive me. I’ve had to remind myself that the cane is a tool to keep me safe.
-
Aug 14, 2025
WellnessOne in seven adolescents worldwide suffers from a mental health disorder. Teen therapy can help pacify the disorderly apadation to early adulthood and make it easier.
-
About PageThe Foundation Fighting Blindness Brand Ambassador Program empowers passionate individuals affected by blinding diseases to share their stories, raise awareness, and inspire action in the fight against vision loss. Together, we’re amplifying voices and accelerating our path to treatments and cures.
-
Aug 8, 2025
Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman
Eye on the CureDr. Christina Ohnsman talks about Tern Therapeutics, a start-up company she co-founded to develop gene therapies for Batten disease and potentially other conditions.
-
Recordings from the 2025 Stargardt's Summit
The Stargardt’s Summit, made possible with the support from Alkeus Pharmaceuticals, was hosted by the Foundation Fighting Blindness, Prevent Blindness, the Carroll Center for the Blind, and The Blind Life. This virtual summit enabled participants to learn about the newest Stargardt research, explore adaptive living resources, hear impactful patient stories, and connect with others going through similar journeys.
-
Donate directly from your IRA to the Foundation Fighting Blindness without counting the gift as taxable income.
-
Aug 5, 2025
Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial
Research NewsSusvimo is an FDA-approved treatment that continuously delivers drug through a tiny, implanted capsule
-
Enjoy 20% off your estate plan purchase.